Perenti shares rose nearly 3% on Monday despite a weaker Australian market, as investors assessed the mining contractor's portfolio transition, new leadership and outlook.
Mike Claire
Nov 02, 2026
NextDC shares rose 3.41% as the data centre operator continued recovering from an eight-year low, despite concerns over its Melbourne power delay, financing and AI infrastructure spending.
Tony Jackson
Nov 02, 2026
Reece shares rose nearly 4% after a volatile week, following first-quarter sales growth driven by Australia and New Zealand despite ongoing weakness in the US housing market.
Mike Claire
Nov 02, 2026
NRW Holdings shares rose 2.78% to A$6.475 on Monday, recovering after recent declines as investors weighed the contractor's strong contract pipeline, diversification and exposure to interest rates.
Tony Jackson
Nov 02, 2026
Tesla has demonstrated a flying version of its Roadster using rocket-inspired thrusters, but production, certification, deliveries and legal everyday use remain uncertain despite a 2028 target.
George Anton
Nov 01, 2026
Alphabet's latest results have intensified concerns that AI-powered search could weaken Google's advertising model, even as cloud revenue surges and the company ramps up spending.
Scott Lance
Nov 01, 2026
SK Hynix and Samsung reported record quarterly profits, yet their shares fell as investors questioned whether Big Tech's huge AI investments can continue and weighed each company's risks.
Scott Lance
Oct 31, 2026
SK Hynix shares fell nearly 7% as a global memory-chip sell-off overshadowed record quarterly results, with investors concerned about AI spending, valuation and future supply risks.
Tony Jackson
Oct 31, 2026
Alphabet shares fell 12.6% in their worst one-day decline after results raised concerns about slowing search growth, surging AI investment, negative free cash flow and broader technology-sector volatility.
Scott Lance
Oct 31, 2026
CareDx shares climbed nearly 24% after third-quarter revenue rose 39% to $139 million, prompting the transplant diagnostics company to raise its 2026 revenue and adjusted EBITDA forecasts.
Tony Jackson
Oct 31, 2026
Capri Holdings shares rose sharply after quarterly revenue exceeded expectations, margins improved and the luxury group returned to profit, despite continued weakness at Michael Kors.
Mike Claire
Oct 31, 2026
BrightSpring Health Services shares rose nearly 16% after third-quarter revenue and profit exceeded expectations, while the company raised its 2026 outlook and reported lower leverage.
Tony Jackson
Oct 31, 2026
FedEx Freight shares rose 13.4% after the newly independent carrier reported stronger pricing, higher adjusted operating income and an improved outlook in its first standalone earnings report.
Mike Claire
Oct 31, 2026
Cavco Industries reported record fiscal second-quarter revenue and higher home sales, sending shares up 13%, while a growing backlog supported demand despite pressure on gross margins.
Tony Jackson
Oct 31, 2026
Alphabet shares plunged after its third-quarter report showed slower search growth, earnings below expectations and negative free cash flow amid surging investment in AI infrastructure.
Tony Jackson
Oct 30, 2026
DoorDash will acquire Instacart for about $17 billion, combining two major US delivery platforms in a deal expected to face extensive regulatory and antitrust scrutiny.
Scott Lance
Oct 30, 2026
Crocs shares jumped nearly 20% after the footwear maker exceeded third-quarter earnings expectations, reported renewed HEYDUDE growth and raised its full-year 2026 forecasts.
Mike Claire
Oct 30, 2026
Mesoblast shares surged in Australia and the US after Ryoncil revenue rose 44%, quarterly cash spending fell sharply and the company reported progress on adult trials and pipeline treatments.
Tony Jackson
Oct 30, 2026
Bausch Health shares rose 17% after the drugmaker reported strong third-quarter results, raised its 2026 guidance and reduced net debt, despite future Medicare pricing risks.
Mike Claire
Oct 30, 2026
Glaukos shares surged after the eye-care company reported record third-quarter sales, raised its 2026 forecast and outlined a preliminary $1 billion revenue target for 2027.
Tony Jackson
Oct 30, 2026
Neuren Pharmaceuticals shares gained 6.3% as investors focused on potential milestone payments, DAYBUE sales growth, European expansion and upcoming Japanese trial results for trofinetide.
Mike Claire
Oct 29, 2026
Mesoblast shares jumped 23.4% after quarterly Ryoncil revenue rose 44% to US$28 million and operational cash spending fell 86% to US$2.1 million.
Mike Claire
Oct 29, 2026
Lynas Rare Earths shares rose 4.2% after record prices lifted quarterly revenue 55%, despite the result missing expectations and sales volumes falling 17.7%.
Mike Claire
Oct 29, 2026
Micron shares rose nearly 5% after SK Hynix reported strong results and said demand for high-bandwidth memory used in AI processors could exceed supply through 2030.
Tony Jackson
Oct 29, 2026
Tesla shares fell after rising on speculation about a possible SpaceX merger. Investors are weighing the uncertain deal alongside weak earnings, high valuations and pressure on vehicle sales.
Mike Claire
Oct 29, 2026
SK Hynix reported record quarterly results, buoyed by AI data-centre demand, and announced a planned 100 trillion won shareholder-return programme for 2026.
Tony Jackson
Oct 29, 2026
Toyota shares fell 1.58% in New York as investors assessed declining profits, weak Chinese sales, tariffs and currency risks ahead of the automaker's half-year results.
Tony Jackson
Oct 29, 2026
Character.AI users reported loading, login and connection problems across several countries, as the AI chatbot company continues bankruptcy proceedings involving a proposed Disney-backed asset sale.
Joe James
Oct 29, 2026
Axogen shares rose nearly 22% after the nerve repair company exceeded third-quarter earnings and revenue expectations, raised its 2026 sales forecast and reported progress on insurance coverage.
Tony Jackson
Oct 29, 2026
Genmab shares rose 16% after encouraging ovarian and colorectal cancer trial results, a JPMorgan upgrade and stronger expectations for its experimental drug pipeline.
Mike Claire
Oct 29, 2026